APDI, Inc. (Alzheimer’s, Parkinson’s, Dementia Impaired)

A Smarter Investment in a Volatile Market

In today’s unstable economic climate, investors are searching for more than just returns—they’re seeking resilience, innovation, and real-world impact. With stock market swings and bond market uncertainty, one sector stands out: neuro-nutraceuticals. The brain health market is exploding in demand, fueled by the aging population and the lack of effective solutions.

APDI, Inc. is not just another supplement company—we’re the breakthrough.

Our flagship product, My Brain Restore™, is a next-generation nutraceutical inspired by a 2025 Japanese university study that showed complete reversal of Parkinson’s, Alzheimer’s, and Lewy Body Dementia symptoms in 100% of the mice tested. Even healthy control mice showed a 20% improvement in cognitive performance. Results like this are virtually unheard of in any preclinical study.

And this is not theoretical—our founder, who battles Parkinson’s and early Alzheimer’s, created and personally uses this formulation. Since January 2025, he’s improved from Stage 3 Parkinson’s to Stage 1—and ran in the Michael J. Fox Foundation marathon. These are tangible, human results.  

 “Our core ingredient is unlike anything currently available—this isn’t a recycled supplement or another trendy extract. It’s a completely reengineered compound, never before used for neurological conditions, and processed with a proprietary method that unlocks its full potential for the first time.” That’s our edge, and it’s unmatchable.”

What Makes This an Exceptional Investment?

• Massive market potential in the $160+ billion supplement and brain health space

• First-mover advantage with a proprietary, patentable product

• Personalized origin with real-world results from the founder himself

• Zero direct competition for our specific formulation and method

• FDA interest rising in allowing broader nutraceutical claims

• Flexible business model: direct-to-consumer, subscription-based, Amazon/Walmart expansion

• Clear exit strategy: scale and exit or dominate the market independently

We’re currently raising $1 million to expand production, scale our operations, and fund clinical validation. Long-term, the right partnership or acquisition could offer massive ROI, especially as the big supplement and pharmaceutical players eye this exploding niche.

Bottom Line

My Brain Restore™ is a nutraceutical with nootropic benefits, sold as a supplement—but positioned like a therapeutic. It offers neurological repair, not just support—based on science, lived experience, and an unmet need that touches tens of millions of lives.

APDI, Inc. Was formed as a Class C corporation in Delaware.

MY BRAIN RESTORE^tm AND ULTRA CHILL MILLED^tm  are filed with the US Patent and Trademark office along with other trademarks owned by APDI, Inc.  

This is more than an investment—it’s a legacy.
Let’s talk. Call Mark at 202-536-5000 or email Mark@MyBrainRestore.com.